NKE
NIKE, Inc.
NKE has the edge over THCH overall, supported by stronger valuation and stronger fundamentals.
THCH
TH International Limited
THCH offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
THCH Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Unavailable |
THCH's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.
THCH PE Valuation
THCH has no meaningful PE right now: it lost money over the past year.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
THCH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect THCH's earnings, revenue and profitability to hold roughly steady.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE has the edge over THCH on earnings quality, reporting a profit while its opponent remains loss making.
THCH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$2.33 | -$0.70 |
| Q1 2026 | -$2.23 | -$0.73 |
| Q4 2025 | -$1.99 | -$0.08 |
| Q3 2025 | -$1.56 | +$1.19 |
| Q2 2025 | -$1.63 | +$1.47 |
| Q1 2025 | -$1.50 | +$2.51 |
| Q4 2024 | -$1.91 | +$2.62 |
| Q3 2024 | -$2.75 | +$2.00 |
THCH is still losing money, but far less than before: $2.33 per share over the past year, against $5.40 at its worst in mid-2023.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE has the edge over THCH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over THCH on profitability, with a higher operating margin.
THCH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.9M | -22% |
| Q1 2026 | $38.3M | -15% |
| Q4 2025 | $45.7M | -8.5% |
| Q3 2025 | $53.7M | -0.4% |
| Q2 2025 | $52.4M | -4.9% |
| Q1 2025 | $45.1M | -9.5% |
| Q4 2024 | $49.9M | -15% |
| Q3 2024 | $54M | -17% |
THCH's revenue has slid since its 2023 peak: $41M last quarter, down 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -20% | -9.2 points |
| Q1 2026 | -26% | -2.2 points |
| Q4 2025 | -28% | +2.1 points |
| Q3 2025 | -15% | -4.6 points |
| Q2 2025 | -11% | +4 points |
| Q1 2025 | -24% | +13 points |
| Q4 2024 | -30% | +29 points |
| Q3 2024 | -11% | +23 points |
THCH's operating margin was −20% last quarter, down 9.2 points from the same quarter a year ago.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE has the edge over THCH on cash generation, producing positive trailing cash flow while its opponent burns cash.
THCH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $5.1M | +$5.3M |
| Q1 2026 | -$3.5M | -$3.5M |
| Q4 2025 | -$11.3M | -$6.5M |
| Q3 2025 | -$257.1K | +$1.7M |
| Q2 2025 | -$176.3K | -104% |
| Q1 2025 | -$32.9K | +$4M |
| Q4 2024 | -$4.7M | +$51.2M |
| Q3 2024 | -$2M | +$2.6M |
THCH has burned cash in almost every quarter: −$10M over the past year, against −$7M the year before.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
THCH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -4.3K shares |
| 3 years | +6.7% | +2M shares |
| 5 years | +21% | +5.6M shares |
| Available history | +21% | +5.6M shares |
THCH has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
THCH hasn't bought back shares in the past year.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
THCH Net Leverage
THCH's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
THCH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.7 | Neutral |
| Stochastic | 33.1 | Neutral |
THCH's weekly RSI is 42 (neutral) and its Stochastic is 33 (neutral).
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
THCH PE vs Consumer Cyclical Sector
THCH has no meaningful PE right now: it lost money over the past year.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
THCH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.17 | 6% above |
| 20 week MA | $1.40 | 11% below |
| 50 week MA | $1.79 | 31% below |
| 100 week MA | $2.32 | 47% below |
| 200 week MA | $6.07 | 80% below |
THCH has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 80% below its 200-week average.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has the edge over THCH on returns for 2026, with the stronger performance.
THCH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $49.1 | $48.9 | -0.4% |
| 2022 | $48.9 | $15.7 | -68% |
| 2023 | $15.7 | $8.75 | -44% |
| 2024 | $8.75 | $3.73 | -57% |
| 2025 | $3.73 | $2.19 | -41% |
| 2026 YTD | $2.19 | $1.24 | -43% |
THCH has finished every year since 2021 lower, and it's down 43% so far in 2026.